Human coagulation factor IX (Sanquin Plasma Products)

N/A

Report date: 2022/01/14 13:23:58

Base Information

Drug NameHuman coagulation factor IX (Sanquin Plasma Products)
Drug Alias NameFactor IX (Sanquin)人凝血因子IXNonafact
ClassificationBiologics > Protein drugs > Non-recombinant coagulation factorBiologics > Blood components > Non-recombinant coagulation factor
Mechanisms of ActionCoagulation factor X stimulantsBlood coagulation pathway activation
TargetsCoagulation factor X
Therapy Area/IndicationsShock, HemorrhagicHemophilia B
Global Approved IndicationsHemophilia B
Approved Indications in ChinaN/A
Original Approved Country/TerritoryEU
Original Approved Date2001/07/03
Country/TerritoryUnited StatesEU
CombinationsNo
Global Highest StatusWithdrawn
Highest Status in ChinaN/A
Originator CompaniesSanquin Plasma Products Bv
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesVirginia Commonwealth UniversitySanquin Plasma Products Bv
Active IndicationsN/A
Inactive IndicationsShock, HemorrhagicHemophilia B

Other Information

ATC CodeB02BD04
Related LinksN/A